Low-dose indacaterol/mometasone improves FEV1 in adolescents, adults with asthma
11 Oct 2019
bởiElaine Soliven
The use of low-dose indacaterol acetate/mometasone furoate (IND/MF), a long-acting β2-agonist/inhaled corticosteroid (LABA/ICS) combination, significantly improves trough FEV1* in symptomatic patients with poorly controlled asthma, according to the QUARTZ** study presented at ERS 2019.